Register and share your invite link to earn from video plays and referrals.

IPO Newsroom
@IPONewsroom_
Your IPO newsroom. S-1 filings, pricing updates, debut coverage, and post-IPO performance.
Joined November 2024
109 Following    31.9K Followers
NOVO HOLDINGS-BACKED REZERA FILES FOR A NASDAQ IPO The clinical-stage company, which is developing oral NLRP3 inhibitors for cardiovascular and neurologic disease, plans to list under RZRA with Jefferies, TD Cowen and Cantor as joint bookrunners. Novo Holdings owned 24.42% and Blue Owl affiliates 24.03% before the IPO, per its SEC filing
Show more